RGNT

Healthcare Medical Instruments & Supplies

Regentis Biomaterials Ltd.

$1.85

+0.02 +1.09% today

Price History

Not enough data

Key Stats

Market Cap

12.99M

Avg Volume

76,398

EPS

-$23.94

52W High

$15.50

52W Low

$1.23

Div. Yield

0.0%

Valuation

P/B Ratio

2.02

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(113.6%)

Liquidity & Leverage

Current Ratio

5.62

Quick Ratio

5.42

Debt / Equity

0.00

Total Cash

8.95M

Total Debt

29,000

About

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.